Multicenter phase ii study of a combination of cyclosporine a, methotrexate and mycophenolate mofetil for GVHD prophylaxis: results of the Chinese Bone Marrow Transplant Cooperative Group (CBMTCG)

BACKGROUND: Improvement of current GVHD prophylactic therapies remains an important goal in the allo-HSCT. We have described a novel prophylaxis regimen in a single institution trial. The Chinese Bone Marrow Transplant Cooperative Group (CBMTCG) initiated a phase II multicenter study. METHODS: The s...

Descripción completa

Detalles Bibliográficos
Autores principales: Lai, Yong-rong, Chen, Yu-hong, Hu, Deng-ming, Jiang, Ming, Liu, Qi-fa, Liu, Lin, Hou, Jian, Schwarzenberger, Paul, Li, Qiao-chuan, Zhang, Zhong-ming, Liu, Kai-yan, Huang, Xiao-jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4237802/
https://www.ncbi.nlm.nih.gov/pubmed/25139202
http://dx.doi.org/10.1186/s13045-014-0059-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4237802/
https://www.ncbi.nlm.nih.gov/pubmed/25139202
http://dx.doi.org/10.1186/s13045-014-0059-3

Ejemplares similares